1.
TÖZÜN N, Sezgin O, GÜLŞEN M, KACAR S, YENİCE N, YILMAZ Şerif, et al. Safety of peginterferon alfa-2a (40KD) treatment in patients with chronic hepatitis B infection: An observational, multicenter, open label, non-interventional study in Turkish patients. Turkish Journal of Gastroenterology [Internet]. 2012 Jan. 5 [cited 2026 Jan. 1];23(5):552-9. Available from: https://www.turkjgastroenterol.org/index.php/tjg/article/view/2128